Tag: arguments
Heads up, Biogen. After digging into Tecfidera patent arguments, analyst predicts a...
As Biogen preps for its closely watched aducanumab FDA filing in Alzheimer’s disease, a patent threat for the company’s top-selling medicine is causing concern...
